In alignment with NIH guidelines, the George Washington University and the GW Cancer Center are committed to transparency and public access to information. This page includes approved minutes from Institutional Biosafety Committee (IBC) meetings, documenting committee discussions and decisions related to biosafety and biosecurity in research involving recombinant or synthetic nucleic acid molecules. By making this information available, GW supports the safe and responsible conduct of research, ensures compliance with regulatory requirements, and reinforces public trust.
2026 Minutes